Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Playstudios, Twitter, Aurinia, and Stronghold and Encourages Investors to Contact the Firm Pharmaceutical Investing
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Volta, Embark, Lucid, and AbbVie and Encourages Investors to Contact the Firm Pharmaceutical Investing
Aurinia Pharmaceuticals Inc. CLASS ACTION Alert: Wolf Haldenstein Adler Freeman & Herz LLP announces that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of New York against Aurinia Pharmaceuticals Inc. Pharmaceutical Investing
Johnson & Johnson to Participate in the Bernstein 38th Annual Strategic Decisions Conference Pharmaceutical Investing
CLASS ACTION UPDATE for ABBV, MYPS and CS: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders Pharmaceutical Investing
Aurinia Pharmaceuticals to Release First Quarter 2022 Financial and Operational Results on May 10, 2022 Pharmaceutical Investing
Rosen, A LEADING LAW FIRM, Encourages AbbVie Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action - ABBV Pharmaceutical Investing
CLASS ACTION UPDATE for LCID, IBM and AUPH: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders Pharmaceutical Investing
ROSEN, Leading Investor Counsel, Encourages Aurinia Pharmaceuticals Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Deadline in Securities Class Action - AUPH Pharmaceutical Investing
Bronstein, Gewirtz & Grossman, LLC Reminds Aurinia Pharmaceuticals Inc. Investors of Class Action and Encourages Investors to Contact the Firm Pharmaceutical Investing
Bronstein, Gewirtz & Grossman, LLC Notifies Shareholders of Bausch Health Companies Investigation Pharmaceutical Investing
Kessler Topaz Meltzer & Check, LLP: Important Deadline Reminder for AbbVie, Inc. Investors in Securities Fraud Class Action Lawsuit Pharmaceutical Investing
